ESC Premium Access

Interruption of antiplatelet therapy: benefits and risks

Session: Bridging of antithrombotic therapy for invasive procedure

Topic: Antithrombotic agents

Speaker: Professor J. Collet (Paris, FR)

Event: ESC CONGRESS 2016


Become an ESC member to access this resource

Become a member

Already a member? Sign in

About the speaker

Professor Jean-Philippe Collet

Sorbonne Universite Pitie Salpetriere Hospital, Paris (France)

17 presentations

0 follower

3 more presentations in this session

Role of intravenous agents

29 August 2016 11:22 - 11:45

Speaker: Professor J. Morais (Leiria, PT)


Oral anticoagulation for atrial fibrillation: interruption or bridging?

29 August 2016 11:45 - 12:07

Speaker: Professor F. Verheugt (Amsterdam, NL)


Resumption of oral antithrombotics

29 August 2016 12:07 - 12:30

Speaker: Professor S. Halvorsen (Oslo, NO)